· 31/03/2016

Proxima A (GX29633)

· 31/03/2016

Proxima B: (GX29639)

· 21/09/2015

HARRIER (RHT258)

· 29/01/2015

CHROMA: Clinical Trial of Lampalizumab for Geographic Atrophy Secondary to Age-Related Macular Degeneration

· 19/12/2014

FOVISTA NR: Clinical Trial for neovascular age-related macular degeneration

· 21/12/2014

LITE: Development of Advanced Laser Imaging Techniques for the anterior and posterior Eye

· 01/01/2015

FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration

· 19/03/2014

Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD

· 31/03/2014

Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD

· 20/12/2014

MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration  

· 20/12/2014

Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD

· 02/07/2014

Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma

· 02/07/2014

JETREA M-13-056 Assessment of anatomical and functional outcomes in patients treated with ocriplasmin for vitreomacular traction/symptomatic vitreomacular adhesion

· 19/03/2014

TREND: A phase IIIb, randomized, a 12-month, Visual Acuity assessor-masked, interventional study assessing the efficacy and safety of the Treat and Extend vs monthly regimens of 0.5 mg ranibizumab in patients with newly diagnosed nAMD

· 19/03/2014

MACBETH. Phase IV Study to evaluate the efficacy of aflibercept in subjects with neovascular Age-related Macular Degeneration (wAMD), without optimal response to repeated monthly intravitreal injections of Anti Vascular Endothelial Growth Factor (Anti VEGF-A) Therapy